Evidence map›Paper›PMID 34378965›Full record

ArticleMicrobiology spectrum2021

Mild and Severe SARS-CoV-2 Infection Induces Respiratory and Intestinal Microbiome Changes in the K18-hACE2 Transgenic Mouse Model.

Brittany Seibert, C Joaquín Cáceres, Stivalis Cardenas-Garcia, Silvia Carnaccini, Ginger Geiger, Daniela S Rajao, Elizabeth Ottesen, Daniel R Perez

Open access · goldAbstract read
In one paragraph

Article in Microbiology spectrum, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.8field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 36 citations in OpenAlex.

  1. Microbiome-Metabolome Crosstalk as a Driver of COVID-19 Severity.Medical sciences (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Observational
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Brittany SeibertDepartment of Population Health, College of Veterinary Medicine, University of Georgiagrid.213876.9, Athens, Georgia, USA.ORCID 0000-0002-5721-5382
C Joaquín CáceresDepartment of Population Health, College of Veterinary Medicine, University of Georgiagrid.213876.9, Athens, Georgia, USA.ORCID 0000-0001-8508-6592
Stivalis Cardenas-GarciaDepartment of Population Health, College of Veterinary Medicine, University of Georgiagrid.213876.9, Athens, Georgia, USA.ORCID 0000-0002-7613-8642
Silvia CarnacciniTifton Diagnostic Laboratory, College of Veterinary Medicine, University of Georgiagrid.213876.9, Tifton, Georgia, USA.ORCID 0000-0002-1656-4068
Ginger GeigerDepartment of Population Health, College of Veterinary Medicine, University of Georgiagrid.213876.9, Athens, Georgia, USA.
Daniela S RajaoDepartment of Population Health, College of Veterinary Medicine, University of Georgiagrid.213876.9, Athens, Georgia, USA.ORCID 0000-0002-0772-0065
Elizabeth OttesenDepartment of Microbiology, University of Georgiagrid.213876.9, Athens, Georgia, USA.ORCID 0000-0002-7898-2425
Daniel R PerezDepartment of Population Health, College of Veterinary Medicine, University of Georgiagrid.213876.9, Athens, Georgia, USA.ORCID 0000-0002-6569-5689
University of Georgia · US

Funding

Development of dual inhibitors targeting the viral main protease and the host cathepsin L as SARS-CoV-2 antiviralsR01AI158775 · NIAID · UNIVERSITY OF ARIZONA · PI Jun Wang · 2021 to 2026
$3.6M
Drug target validation of the enterovirus D68 2A proteaseR01AI157046 · NIAID · UNIVERSITY OF ARIZONA · PI WANG, JUN · 2020 to 2024
$3.4M
Role of spatial structure in shaping viral population diversity and evolutionR01AI154894 · NIAID · EMORY UNIVERSITY · PI KOELLE, KATHARINA V, LOWEN, ANICE C · 2020 to 2024
$2.8M
Dissecting host and microbial contributions to gut microbiome homeostasisR35GM133789 · NIGMS · UNIVERSITY OF GEORGIA · PI OTTESEN, ELIZABETH A · 2019 to 2023
$1.9M
High Throughput Screening of Inhibitors Targeting the Enterovirus A71 and D68 2A ProteasesR01AI147325 · NIAID · UNIVERSITY OF ARIZONA · PI WANG, JUN · 2019 to 2022
$1.7M
Drug Discovery Targeting the Influenza A Virus M2-S31N Proton ChannelR33AI119187 · NIAID · UNIVERSITY OF ARIZONA · PI PEREZ, DANIEL R, WANG, JUN · 2017 to 2019
$1.2M
NIAID NIH HHS HHSN272201400008CNIAID NIH HHS R01 AI147325NIAID NIH HHS R01 AI154894NIAID NIH HHS R01 AI157046NIAID NIH HHS R01 AI158775NIAID NIH HHS R33 AI119187NIGMS NIH HHS R35 GM133789
6 · The paper itself

Abstract

Transmission of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has resulted in millions of deaths and declining economies around the world. K18-hACE2 mice develop disease resembling severe SARS-CoV-2 infection in a virus dose-dependent manner. The relationship between SARS-CoV-2 and the intestinal or respiratory microbiome is not fully understood. In this context, we characterized the cecal and lung microbiomes of SARS-CoV-2-challenged K18-hACE2 transgenic mice in the presence or absence of treatment with the M

Indexed as

SARS-CoV-2Angiotensin-Converting Enzyme 2AnimalsAntiviral AgentsBiodiversityCOVID-19Disease Models, AnimalFemalegamma-GlobulinsGastrointestinal MicrobiomeLungMelphalanMiceMice, TransgenicVirus DiseasesACE2 protein, humanAngiotensin-Converting Enzyme 2Antiviral Agentsgamma-GlobulinsK-18 conjugateMelphalancecumCOVID-19intestinelungmicrobiomemouserespiratory infectionSARS-CoV-2

Identifiers

PMID34378965
PMCPMC8455067
OpenAlexW3190699771

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.